Does RIVAROXABAN Cause Wound secretion? 25 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Wound secretion have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.0% of all adverse event reports for RIVAROXABAN.
25
Reports of Wound secretion with RIVAROXABAN
0.0%
of all RIVAROXABAN reports
0
Deaths
6
Hospitalizations
How Dangerous Is Wound secretion From RIVAROXABAN?
Of the 25 reports, 6 (24.0%) required hospitalization, and 2 (8.0%) were considered life-threatening.
Is Wound secretion Listed in the Official Label?
Yes, Wound secretion is listed as a known adverse reaction in the official FDA drug label for RIVAROXABAN.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Wound secretion?
ADALIMUMAB (407)
PREDNISONE (148)
OMALIZUMAB (105)
BECAPLERMIN (86)
METFORMIN (84)
ATORVASTATIN (81)
ALENDRONATE (77)
INFLIXIMAB (73)
CLONAZEPAM (72)
DILTIAZEM (70)
Which RIVAROXABAN Alternatives Have Lower Wound secretion Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM